Belluscura Signs Supply Agreement with the Largest Member Service Organisation (MSO) in the US

VGM & Associates MSO comprises over 2,500 providers with nearly 7,000 locations

Belluscura, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has entered into a Group Purchasing Organization Product Supply Agreement (the “Agreement”) for the supply of portable oxygen concentrators with VGM Group, Inc (“VGM”).

VGM is the largest and most comprehensive Member Service Organization (“MSO”) in the US for post-acute healthcare, which provides a range of support to its members including with the purchasing of medical equipment in the respiratory field.

Over 2,500 healthcare providers with nearly 7,000 locations across the US rely on VGM to connect them to valuable resources every single day.

VGM’s providers will immediately gain access to Belluscura’s award winning next generation portable oxygen concentrator, the X-PLOR®, which was launched in late June 2022, and later this year will gain access to Belluscura’s transformational portable oxygen concentrator, the DISCOV-R™.

The Agreement with VGM further expands Belluscura’s distribution network across the US and its routes to market.

Robert Rauker, CEO of Belluscura plc, said: “Our partnership with VGM enables us to work together to provide access to our next generation portable oxygen concentrators. The partnership provides a further opportunity to support the Group’s continued growth. We look forward to working with VGM in expanding access to our high performing, lighter oxygen technologies and improving the quality of life for patients.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”